The determination of the peripheral plasma level of progesterone was evaluated as a clinical aid in the gynaecological diagnosis of female pigs. The normal cyclic variation of the peripheral plasma level of progesterone was determined in six cross bred gilts (Swedish Landrace times Swedish Yorkshire Breed) which were examined daily for the stages of oestrus. The results of this investigation are given in fig. 1. Peripheral plasma levels of progesterone were determined in 16 gilts with the clinical diagnosis of "silent heat". Despite all 16 gilts being sexually mature none of them had shown clinical signs of heat. The gilts belonged to 3 different farms, on all of which there was a high incidence of "silent heat". At least two blood samples were drawn 7 days apart from each of the gilts. Of the gilts examined 12 had variations in peripheral plasma level of progesterone. Of these 12 animals only 5 had clinical signs of heat, although the farmer had been advised, from the progesterone analysis, on the probable day of occurrence of heat. In 3 of the gilts, treatment with hormones (PMSCG) elicited the standing reflex when they were placed with a boar. In Table I is given some examples of the relationship of clinical signs of heat and the peripheral plasma level of progesterone. The peripheral plasma level of progesterone was also used as an early pregnancy diagnosis test in gilts. The gilts used in this investigation were all artificially inseminated with deep frozen boar semen. The expected pregnancy rate after insemination was 50%. Blood samples were drawn 17-25 days after insemination of 84 gilts. Peripheral plasma level of progesterone equal to or higher than 7.5 ng/ml were considered to indicate pregnancy. All gilts were slaughtered 4 weeks after the insemination and the number of fetuses were counted. A correct pregnancy diagnosis by the estimation of peripheral plasma level of progesterone was obtained in 95.2% of the gilts. The incorrect diagnoses were all false positives, viz. non-pregnant gilts were diagnosed as pregnant.
Download full-text PDF |
Source |
---|
Anal Chem
January 2025
Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, Fujian Normal University, Fuzhou, Fujian 350117, China.
Multiple myeloma is a hematologic malignancy characterized by the proliferation of abnormal plasma cells in the bone marrow. Despite therapeutic advancements, there remains a critical need for reliable, noninvasive methods to monitor multiple myeloma. Circulating plasma cells (CPCs) in peripheral blood are robust and independent prognostic markers, but their detection is challenging due to their low abundance.
View Article and Find Full Text PDFScand J Med Sci Sports
February 2025
Sports Performance Laboratory, School of Physical Education and Sport Science, National and Kapodistrian University of Athens, Athens, Greece.
The purpose of the study was to investigate the effects of exercise training on the bone marrow immune microenvironment and on minimal residual disease of multiple myeloma patients who completed first-line induction treatment. Eight multiple myeloma patients underwent 5 months of exercise training along with standard medical treatment. Eight age- and sex-matched patients who received medical treatment only, served as controls.
View Article and Find Full Text PDFCancer Chemother Pharmacol
January 2025
Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan.
Purpose: A comprehensive analysis of metabolites (metabolomics) has been proposed as a new strategy for analyzing liquid biopsies and has been applied to identify biomarkers predicting clinical responses or adverse events associated with specific treatments. Here, we aimed to identify metabolites associated with bortezomib (Btz)-related toxicities and response to treatment in newly diagnosed multiple myeloma (MM).
Methods: Fifty-four plasma samples from transplant-ineligible MM patients enrolled in a randomized phase II study comparing two less-intensive regimens of melphalan, prednisolone and Btz (MPB) were subjected to the lipidomic profiling analysis.
Front Pharmacol
January 2025
Department of Pharmacy, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Objectives: To assess the pharmacokinetics and pharmacodynamics of imipenem in a retrospective cohort of hospitalized Chinese older patients.
Methods: A population pharmacokinetic (PPK) model was constructed utilizing a nonlinear mixed-effects modeling approach. The final model underwent evaluation through bootstrap resampling and visual predictive checks.
World J Oncol
February 2025
Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.
The investigation of microRNAs (miRNAs) for the purpose of identifying biomarkers and new treatments for breast cancer has been gaining traction from scientists in recent years. Of all the miRNAs, miR-155 has been reportedly involved in breast cancer development as it regulates various cellular processes such as glucose uptake, proliferation, metastasis, and migration. Various efforts have been done towards researching miR-155 as a biomarker in breast cancer; however, the results were varied.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!